LEADER 00000nam  2200397 i 4500 
001    956434152 
003    OCoLC 
005    20160810085135.0 
006    m     o  d f       
007    cr mn||||||||| 
008    160810s2009    dcua    ob   f000 0 eng c 
040    GPO|beng|erda|epn|cGPO|dMvI 
042    pcc 
043    n-us--- 
074    0445-B-07 (online) 
086 0  HE 1.75:OEI-05-07-00730 
110 1  United States.|bDepartment of Health and Human Services.
       |bOffice of Inspector General,|eauthor. 
245 14 The Food and Drug Administration's oversight of clinical 
       investigators' financial information. 
246 1  |iRunning title:|aFDA's oversight of clinical 
       investigators' financial information. 
264  1 [Washington, D.C.] :|bDepartment of Health and Human 
       Services, Office of Inspector General,|c2009. 
300    1 online resource (iv, 44 pages) :|billustrations 
336    text|2rdacontent. 
337    computer|2rdamedia. 
338    online resource|2rdacarrier. 
500    Title from title screen (viewed Aug 9, 2016). 
500    "January 2009." 
500    "OEI-05-07-00730." 
504    Includes bibliographical references. 
610 10 United States.|bFood and Drug Administration|xRules and 
       practice|xEvaluation. 
650  0 Medical research personnel|zUnited States|xFinance, 
       Personal. 
650  0 Clinical trials|xFinance|xAuditing. 
650  0 Corruption|zUnited States|xAuditing. 
856 40 |uhttp://purl.fdlp.gov/GPO/gpo71052 
LOCATION CALL # STATUS
 Internet  Electronic Report    AVAILABLE